NeuroVive Pharmaceutical AB Beta
Mi az NeuroVive Pharmaceutical AB Beta?
A Beta az NeuroVive Pharmaceutical AB - 0.93
Mi a Beta meghatározása?
A BETA azt jelzi, hogy az állomány több-kevésbé volatilis, mint a piac egésze. Az 1-nél kevesebb béta azt jelzi, hogy az állomány kevésbé ingadozó, mint a piac, míg az 1-nél nagyobb béta azt jelzi, hogy az állomány volatilisabb. A volatilitást az átlag körüli ár ingadozásaként méri.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta a Health Care szektor a OTC-on cégekben a NeuroVive Pharmaceutical AB -hoz képest
Mit csinál NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
beta -hoz hasonló cégek NeuroVive Pharmaceutical AB
- Megasoft nak Beta 0.93 van
- Manitex International Inc nak Beta 0.93 van
- Premier Gold Mines nak Beta 0.93 van
- Premier Gold Mines nak Beta 0.93 van
- Premier Gold Mines nak Beta 0.93 van
- BAIC Motor nak Beta 0.93 van
- NeuroVive Pharmaceutical AB nak Beta 0.93 van
- iCar Asia nak Beta 0.93 van
- Wesbanco nak Beta 0.93 van
- Sumitomo Mitsui Inc nak Beta 0.93 van
- Midnight Sun Mining nak Beta 0.93 van
- Bio-Rad Laboratories nak Beta 0.93 van
- Foncière Euris SA nak Beta 0.93 van